Athletes can feel the relief a substance gives them long before they can see what it costs. A composite case of cannabis use in a track athlete shows how to assess both.
|Poll|August 13, 2020
Poll: Are Your Patients Reporting Election-Anxiety Symptoms?
Author(s)Heidi Anne Duerr, MPH
As cultural issues collide with science, what concerns do you have for the health of your patients?
Advertisement
Tensions continue to run high in the country due to record unemployment rates, the threat of the pandemic, and the rise of awareness of sociocultural issues.
Election Anxiety—Is It a “Thing”? Have you seen “election anxiety” in your patients?
Join the discussion by writing us at
Advertisement
Related to this article
Seaport begins phase 2a trial of GlyphAgo for generalized anxiety disorder with sleep disturbance, testing liver-sparing agomelatine dosing and tracking sleep, anxiety outcomes.
Don't miss out on these CME articles! Test your knowledge here.
Advertisement
Advertisement
Trending on Psychiatric Times
1
The New, Impending Adult ADHD Guidelines
2
Moving Away From Treatment-Resistant Depression and Toward Difficult-to-Treat Depression
3
Relief Is Not Free: A Case Study of Athlete Cannabis Use
4
Formulations Matter: The Approval of Olanzapine Extended-Release Injectable Suspension for Schizophrenia
5